Skip to main content

Table 2 Distribution of radiologically active bone lesions at baseline and after one year of pamidronate therapy

From: Standardized reporting and quantification of whole-body MRI findings in children with chronic non-bacterial osteomyelitis treated with pamidronate

 

Baseline

Year 1

Baseline

Year 1

P-value

RAL n (%)

RAL n (%)

Children n (%)

Children n (%)

Head

1 (1)

1 (2)

1 (6)

1 (6)

-

 Mandibula

1 (1)

1 (2)

1 (6)

1 (6)

 

Chest

6 (5)

5 (8)

6 (33)

5 (28)

0.5

 Clavicula

3 (3)

3 (5)

3 (17)

3 (17)

 

 Sternum

1 (1)

0

1 (6)

0

 

 Scapula*

2 (2)

2 (3)

2 (11)

2 (11)

 

Upper extremities

4 (4)

0

3 (17)

0

0.13

 Proximal humerus

1 (1)

0

1 (6)

0

 

 Distal humerus

1 (1)

0

1 (6)

0

 

 Proximal radius/ulna

1 (1)

0

1 (6)

0

 

 Distal radius/ulna

1 (1)

0

1 (6)

0

 

Pelvis

21 (19)

13 (21)

10 (56)

8 (44)

0.06

 Pelvis-ileum*

11 (10)

5 (8)

8 (44)

4 (22)

 

 Pelvis-pubis

1 (1)

1 (2)

1 (6)

1 (6)

 

 Pelvis-ischium

2 (2)

3 (5)

2 (11)

3 (17)

 

 Pelvis-sacrum

7 (6)

4 (7)

6 (33)

4 (22)

 

Distal extremities

49 (45)

26 (43)

16 (89)

9 (50)

 < 0.01

 Proximal femur*

10 (9)

6 (10)

7 (39)

3 (17)

 

 Distal femur

8 (7)

3 (5)

6 (33)

2 (11)

 

 Proximal tibia*

11 (10)

4 (7)

9 (50)

3 (17)

 

 Distal tibia*

15 (14)

9 (15)

9 (50)

6 (33)

 

 Proximal fibula

0

0

0

0

 

 Distal fibula

5 (4)

4 (7)

4 (22)

3 (17)

 

Feet

13 (12)

10 (17)

8 (44)

6 (33)

0.55

 Foot-calcaneus *

5 (4)

6 (10)

4 (22)

4 (22)

 

 Foot- talus*

3 (3)

2 (3)

3 (17)

2 (11)

 

 Foot-middle

5 (4)

2 (3)

4 (22)

1 (6)

 

Spine

16 (15)

6 (10)

6 (33)

3 (17)

 < 0.01

 Cervical vertebra

0

0

0

0

 

 Thoracic vertebra*

15 (14)

2 (3)

5 (28)

2 (11)

 

 Lumbar vertebra*

1 (1)

4 (7)

1 (6)

1 (6)

 

Total

110 (100)

61 (100)

-

-

 
  1. Distribution of radiologically active lesions (RALs) at baseline and after one year of pamidronate treatment (n = 18). Anatomic locations were categorized into seven anatomic regions. Anatomic distribution of RALs was assessed by WBMRI prior to and following one year of pamidronate treatment. RALs are presented as number (and percentage of total RALs) prior to pamidronate (total 110 RAL) and year one (total 61 RAL). RALs are also presented as number of children (and percentage of 18 children) with RALs at the different anatomic locations. McNemar´s test was used to compare distribution of RALs in children during pamidronate treatment. P-value < 0.05 was considered significant. *Indicates anatomic locations with new RAL at year one